Alpha Profiles · Company Profile

CORCEPT THERAPEUTICS INC

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/corcept-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: CORT
Verification: Partially verified
Last reviewed: 2026-09-21T04:45:33.882529+00:00

Overview

Alpha's canonical identity and public leadership record for CORCEPT THERAPEUTICS INC.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

9 public records

Atabak Mokari

Chief Financial Officer and Treasurer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-025735Apr 17, 2026

Charles Robb

Chief Business Officer and Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-025735Apr 17, 2026

G. Leonard Baker

Chief Executive Officer

State: confirmed
Effective: From Feb 24, 2026
Confidence: 94%
Evidence: CORT 10-K executive officersFeb 24, 2026

Hazel Hunt

Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-025735Apr 17, 2026

James N. Wilson

Chief Business Officer

State: confirmed
Effective: From Feb 24, 2026
Confidence: 94%
Evidence: CORT 10-K executive officersFeb 24, 2026

Joseph D. Lyon

Chief Accounting and Technology Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-025735Apr 17, 2026

Joseph K. Belanoff

Chief Executive Officer and President

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-025735Apr 17, 2026

Sean Maduck

President, Corcept Endocrinology

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-025735Apr 17, 2026

William Guyer

Chief Development Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001628280-26-025735Apr 17, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 21, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.